Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.23 +0.28 (+1.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Current Assets (2020 - 2026)

Updated

Cullinan Therapeutics' Current Assets was $341.97 million in Q2 2026, up 23.9% from $275.91 million a year earlier but down 5.4% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, Current Assets at Cullinan Therapeutics came in at $386.76 million, down 6.7% from FY2024.

  • Current Assets shows a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
  • In earlier years, Current Assets was $414.67 million in FY2024 (-13.6%), $480.19 million in FY2023 (+1.2%), $474.47 million in FY2022 (+60.0%) and $296.56 million in FY2021 (+39.7%).
  • Quarterly Current Assets has moved between $275.91 million (Q2 2025) and $677.8 million (Q2 2024) over five years.
  • Compared with a year earlier, Current Assets was higher in three of the last eight quarters, with an average decline of 11.1%.
  • The best year-over-year quarter for Current Assets over five years was Q2 2022 (growth of 80.8%); the worst was Q2 2025 (a decline of 59.3%).
  • Per Business Quant data, CGEM's Current Assets in the three quarters before Q2 2026 was $361.41 million (Q1 2026), $386.76 million (Q4 2025) and $342.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Cullinan Therapeutics 961.97 Mn 961.97 Mn - 341.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 341.97 Mn
Mar 31, 2026 361.41 Mn
Dec 31, 2025 386.76 Mn
Sep 30, 2025 342.24 Mn
Jun 30, 2025 275.91 Mn
Mar 31, 2025 317.77 Mn
Dec 31, 2024 414.67 Mn
Sep 30, 2024 592.04 Mn
Jun 30, 2024 677.80 Mn
Mar 31, 2024 445.72 Mn
Dec 31, 2023 480.19 Mn
Sep 30, 2023 476.71 Mn
Jun 30, 2023 498.24 Mn
Mar 31, 2023 399.03 Mn
Dec 31, 2022 474.47 Mn
Sep 30, 2022 582.08 Mn
Jun 30, 2022 622.84 Mn
Mar 31, 2022 322.31 Mn
Dec 31, 2021 296.56 Mn
Sep 30, 2021 328.84 Mn
API Access

Cullinan Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=CGEM&period=max&api_key=YOUR_API_KEY